Morningstar

Gemelli Biotech's Trio-Smart® 3-Gas Breath Test and IBS-Smart® Blood Test, Featured Across Multiple Research Presentations at DDW 2026

Gemelli Biotech's Trio-Smart® 3-Gas Breath Test and IBS-Smart® Blood Test, Featured Across Multiple Research Presentations at DDW 2026 Studies utilizing Gemelli’s proprietary diagnostic technologies ...
Nasdaq

Biomerica Submits PLA Code Application to Enhance Patient Access to inFoods® IBS Diagnostic Test

Biomerica applies for a PLA code to enhance patient access to its inFoods IBS diagnostic test for personalized IBS management. Biomerica, Inc. has submitted an application to the American Medical ...
Nasdaq

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

IRVINE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, is excited to announce a major enhancement to its inFoods® ...
Yahoo Finance

Gemelli Biotech's Trio-Smart® 3-Gas Breath Test and IBS-Smart® Blood Test, Featured Across Multiple Research Presentations at DDW 2026

Studies utilizing Gemelli’s proprietary diagnostic technologies demonstrate key clinical applications, advancements in IBS and SIBO diagnostics, and treatment support. These findings will be presented ...